Follow on Google News News By Tag * Oracle Clinical * Remote Data Capture * Thesaurus Management System * Clinical Data Management * BioPharm Systems * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | BioPharm Systems Launches Accel-Account Manager for Managing Oracle Clinical, RDC and TMS AccountsAccel-Account Manager allows life sciences companies to easily and cost-effectively manage user accounts without technical knowledge.
By: BioPharm Systems Accel-Account Manager is a simple and easy-to-use clinical account management solution that aides users of Oracle Clinical (OC), Remote Data Capture (RDC) and Thesaurus Management System (TMS) in the creation and maintenance of accounts. "A serious pain point for many companies has been creating and managing user accounts," said Michelle Engler, developer of Accel-Account Manager, BioPharm Systems. "The current process requires many technical resources to get involved, takes too long, and is error-prone. Common operations, such as creating accounts, resetting passwords, and assigning RDC study site security, bog down resources and ultimately decreases productivity. We believe Accel-Account Manager is an innovative solution that tackles these challenges at an affordable price." To learn more about Accel-Account Manager, please register for one of BioPharm Systems' upcoming webinars: April 12, 2012 at 9:00 a.m. (Eastern Time) or April 12, 2012 at 2:00 p.m. (Eastern Time) BioPharm Systems is also an Oracle Accelerate solution provider. About Oracle Accelerate Oracle Accelerate is Oracle's approach to provide rapid implementation business software solutions to midsize organizations. Oracle Accelerate solutions include Oracle's enterprise-class software delivered with business accelerators by expert implementers. Business accelerators are rapid implementation tools, templates and industry- and geography-specific leading practice process flows to help dramatically reduce implementation time, complexity, cost, and risk. To find out more, visit oracle.com/accelerate. About Oracle PartnerNetwork Oracle PartnerNetwork (OPN) Specialized is the latest version of Oracle's partner program that provides partners with tools to better develop, sell and implement Oracle solutions. OPN Specialized offers resources to train and support specialized knowledge of Oracle products and solutions and has evolved to recognize Oracle's growing product portfolio, partner base and business opportunity. Key to the latest enhancements to OPN is the ability for partners to differentiate through Specializations. Specializations are achieved through competency development, business results, expertise, and proven success. To find out more, visit oracle.com/partners. About BioPharm Systems BioPharm Systems is an IT consulting company that focuses on the life sciences industry. We have extensive experience in the implementation, integration, migration, upgrade, and hosting of the following Oracle clinical trial management, drug safety and pharmacovigilance, clinical data warehousing and analytics, clinical data management, and electronic data capture systems: -Adverse Event Reporting System (AERS) -Argus Safety Suite (Argus Safety, Affiliate, Interchange, Dossier, Insight, and Perceptive) -Clinical Development Analytics (CDA) -Empirica Signal and Empirica Topics -Life Sciences Data Hub (LSH) -Oracle Clinical -Remote Data Capture (RDC) -Siebel Clinical -Thesaurus Management System (TMS) Founded in 1995 and headquartered in California, BioPharm Systems has offices in the United States and the United Kingdom. To learn more about the company's products and services, please call +1 877 654 0033 (U.S.), +44 (0) 1865 910200 (U.K.), or e-mail info(at)biopharm( Trademarks Oracle and Java are registered trademarks of Oracle and/or its affiliates. North America Sales Contact: Rod Roderick rroderick(at) +1 877 654 0033 Europe/Middle East/Africa Sales Contact: Rudolf Coetzee rcoetzee(at) +44 (0) 1865 910200 Communications Contact: Eugene Sefanov esefanov(at) +1 617 795 2032 Twitter: twitter.com/ Facebook: facebook.com/ LinkedIn: linkedin.com/ YouTube: youtube.com/ Google+: plus.google.com/ End
|
|